ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 14 filers reported holding ENDOLOGIX INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $190,000 | -27.2% | 275,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $261,000 | +146.2% | 275,000 | +120.0% | 0.00% | +200.0% |
| Q1 2018 | $106,000 | -5.4% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $112,000 | -99.3% | 125,000 | -99.3% | 0.00% | -99.5% |
| Q2 2017 | $15,133,000 | -26.5% | 17,980,000 | -14.0% | 0.19% | -40.0% |
| Q1 2017 | $20,591,000 | +12.8% | 20,905,000 | 0.0% | 0.32% | +35.6% |
| Q4 2016 | $18,254,000 | -18.3% | 20,905,000 | +23.7% | 0.24% | -29.3% |
| Q3 2016 | $22,349,000 | +53.5% | 16,900,000 | +51.6% | 0.33% | +51.1% |
| Q2 2016 | $14,563,000 | +35.9% | 11,150,000 | 0.0% | 0.22% | -27.5% |
| Q1 2016 | $10,714,000 | -10.3% | 11,150,000 | +1.4% | 0.30% | +18.7% |
| Q4 2015 | $11,949,000 | – | 11,000,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,500,000 | $3,793,000 | 5.91% |
| FNY Managed Accounts LLC | 500,000 | $542,190,000 | 2.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 30,000,000 | $32,548,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 13,906,000 | $15,123,000 | 0.71% |
| DAFNA Capital Management LLC | 500,000 | $545,000 | 0.49% |
| SSI INVESTMENT MANAGEMENT LLC | 4,000,000 | $4,308,000 | 0.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,100,000 | $9,868,000 | 0.31% |
| LINDEN ADVISORS LP | 4,500,000 | $4,896,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,000,000 | $11,949,000 | 0.26% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 300,000 | $327,000 | 0.05% |